Cowen Healthcare Investments announced the successful closing of Cowen Healthcare Investments IV (CHI IV) with total committed capital of $555.6 million. CHI IV had received commitments from a wide cross-section of limited partners including institutional investors, wealth managers, family offices, and high net-worth individuals. CHI IV is going to invest primarily in mid to late-stage life sciences opportunities.
Led by Kevin Raidy, Tim Anderson, and Robert Sine, Cowen Healthcare Investments supports innovation in the healthcare space, with a focus on biopharma, diagnostics, and digital health. And as the industry has evolved, Cowen Healthcare Investments’ strategy has adapted to capitalize on significant value-creation opportunities available in both the private and public markets. Since being founded in 2012, the CHI team has invested privately in over 60 healthcare companies and CHI manages more than $1 billion.
KEY QUOTES:
“The success of Cowen Healthcare Investments’ platform is rooted in our exceptional team and our expertise in supporting the growth of emerging biotech companies to drive investor returns. As a result of our focus on financing disruptive businesses, we are thrilled to receive the continued support of our investment partners, both new and existing, who recognize our differentiated investment approach. We will continue to seek life sciences investment opportunities with exciting potential to advance the healthcare landscape.”
— Kevin Raidy, Managing Partner, Cowen Healthcare Investments
“The continued evolution of Cowen Healthcare Investments has made it a top-performing strategy within the Cowen Investment Management division. With Cowen Healthcare Investments expanding its investment tools to now allow it to invest in the public markets, this new fund, CHI IV, will further capture value creation opportunities by seizing upon attractive entry points generated by regular market volatility. We are proud to have secured the trust of our investment partners for our vision and I believe the CHI team will continue to build impactful, life-changing businesses while delivering robust returns.”
— Elizabeth Flisser Rosman, Head of Cowen Investment Management
